Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Mellett Paul J
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
Chief Fin. & Admin Officer
Avg. Two Year Performance
No Purchase Track Record
33%
Avg. Sale Return
15%
Compound
Holdings:
95.9K
shares
Last Three Months: 19-Feb-24 -- 18-May-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
19-May-22 -- 18-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions